Skip to main content
SpringerLink
Log in

A Defence of the Randomized Controlled Trial in Mental Health

  • Commentary
  • Published:
BioSocieties Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 1 An earlier version of this paper appeared as ‘The randomised controlled trial’, in M. Slade, & S. Priebe (Eds), Choosing methods in mental health research (London: Routledge, 2006: 85–98). Some of the material is also used in B. Everitt, & S. Wessely, The randomised controlled trial in psychiatry (Oxford University Press, 2005).

References

  • Anon. (1990). Flawed study's mixed effects. In Hospital Doctor, 18 October.

  • Antman E., Lau J., Kupelnick B., Mosteller F., & Chalmers T. (1992). A comparison of results of meta-analyses of randomized controlled trials and the recommendations of clinical experts. Journal of the American Medical Association, 268, 240–248.

    Article  Google Scholar 

  • Barrowclough C., Haddock G., Tarrier N., Lewis S.W., Moring J., O'Brien R. et al. (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorder. American Journal of Psychiatry, 158, 1706–1713.

    Article  Google Scholar 

  • Byar D. (1978). Sound advice for conducting clinical trials. New England Journal of Medicine, 297, 553–554.

    Article  Google Scholar 

  • Chalmers I. (2001). Comparing like with like: Some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments. International Journal of Epidemiology, 30, 1156–1164.

    Article  Google Scholar 

  • Chalmers T., Matta R., Smith H., & Kunzler A. (1977). Evidence favouring the use of antidepressants in the hospital phase of acute myocardial infarction. New England Journal of Medicine, 297, 1091–1096.

    Article  Google Scholar 

  • Chalmers T., Celano P., Sacks H., & Smith H. (1983). Bias in treatment assignment in controlled clinical trials. New England Journal of Medicine, 309, 1358–1361.

    Article  Google Scholar 

  • Collins R., Peto R., Gray R., & Parish S. (1996). Large-scale randomized evidence: trials and overviews. In Weatherall D. Ledingham J. & Warrell D. (Eds), Oxford Textbook of Medicine, 21–32. Oxford: Oxford University Press.

    Google Scholar 

  • Dehue T. (2002). A Dutch treat: Randomized controlled experimentation and the case of heroin maintenance in the Netherlands. History of the Human Sciences, 15, 75–98.

    Article  Google Scholar 

  • Doll R. (1998). Controlled trials: The 1948 watershed. British Medical Journal, 317, 1217–1220.

    Article  Google Scholar 

  • van Emmerik A., Kamphuis J., Hulsbosch A., & Emmelkamp P. (2002). Single session debriefing after psychological trauma: A meta-analysis. The Lancet, 360, 741–742.

    Article  Google Scholar 

  • Gilbody S., Wahlbeck K., & Adams C. (2002). Randomized controlled trials in schizophrenia: A critical perspective on the literature. Acta Psychiatrica Scandinavica, 105, 243–251.

    Article  Google Scholar 

  • Gist R. (2002). What have they done to my song? Social science, social movements and the debriefing debates. Cognitive and Behavioral Practice, 9, 273–279.

    Article  Google Scholar 

  • Harrington A. (2006). The many meanings of the placebo effect:Where they came from, why they matter. BioSciences, 1, 181–193.

    Google Scholar 

  • Healy D. (1997). The antidepressant era. Cambridge, MA: Harvard University Press.

    Google Scholar 

  • Horton R. (2001). The clinical trial: Deceitful, disputable, unbelievable, unhelpful, and shameful—what next? Controlled Clinical Trials, 22, 593–604.

    Article  Google Scholar 

  • Hotopf M., Lewis G., & Normand C. (1997). Putting trials on trial—the costs and consequences of small trials in depression: A systematic review of methodology. Journal of Epidemiology and Community Health, 51, 354–358.

    Article  Google Scholar 

  • Hrobjartsson A., & Gotzsche P. (2001). Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine, 344, 1594–1602.

    Article  Google Scholar 

  • Kaptchuk T. (1998). Intentional ignorance: A history of blind assessment and placebo controls in medicine. Bulletin of the History of Medicine, 72, 389–433.

    Article  Google Scholar 

  • Kleijnen J., Gotzsche P., Kunz R., Oxman A., & Chalmers I. (1997). So what's so special about randomisation. In Maynard A., & Chalmers I. (Eds), Non-random reflections on health services research: On the 25th anniversary of Archie Cochrane's Effectiveness and Efficiency, 93–106. London: BMJ Publishing Group.

    Google Scholar 

  • Kunz R., & Oxman A. (1998). The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. British Medical Journal, 317, 1185–1190.

    Article  Google Scholar 

  • McKee M., Britton A., Black N., McPherson K., Sanderson C., & Bain C. (1999). Interpreting the evidence: Choosing between randomised and non-randomised studies. British Medical Journal, 319, 312–315.

    Article  Google Scholar 

  • MRC (Medical Research Council) (1965). Clinical trial of the treatment of depressive illness. British Medical Journal, i, 881–886.

  • Persons J., & Silberschatz G. (1998). Are results of randomized controlled trials useful to psychotherapists? Journal of Consulting and Clinical Psychology, 66, 126–135.

    Article  Google Scholar 

  • Rothwell P. (1995). Can overall results of clinical trials be applied to all patients? The Lancet, 345, 1616–1619.

    Article  Google Scholar 

  • Sacks H., Chalmers T., & Smith H. (1982). Randomized versus historical controls for clinical trials. American Journal of Medicine, 72, 233–240.

    Article  Google Scholar 

  • Sacks H., Berrier J., Reitman D., Ancona-Berk V., & Chalmers T. (1987). Meta-analyses of randomized controlled trials. New England Journal of Medicine, 316, 450–455.

    Article  Google Scholar 

  • Schultz K., & Grimes D. (2002). Allocation concealment in randomised trials: Defending against deciphering. The Lancet, 359, 614–618.

    Article  Google Scholar 

  • Schultz K., Chalmers I., Grimes D., & Altman D. (1994). Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynaecology journals. Journal of the American Medical Association, 272, 125–128.

    Article  Google Scholar 

  • Schultz K., Chalmers I., Hayes R., & Altman D. (1995). Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatments effects in controlled trials. Journal of the American Medical Association, 273, 408–412.

    Article  Google Scholar 

  • Shelton R.C., Keller M., Gelenberg A., Dunner D.L., Hirschfeld R., Thase M.E. et al. (2001). Effectiveness of St John's wort in major depression—A randomized controlled trial. Journal of the American Medical Association, 285, 1978–1986.

    Article  Google Scholar 

  • Sibbald B., & Roland M. (1998). Why are randomised controlled trials important? British Medical Journal, 316, 201.

    Article  Google Scholar 

  • Swartz M.S., Swanson J., Hiday V.A., Wagner H.R., Burns B.J., & Borum R. (2001). A randomized controlled trial of outpatient commitment in North Carolina. Psychiatric Services, 52, 325–329.

    Article  Google Scholar 

  • Thornley B., & Adams C. (1998). Content and quality of 2000 controlled trials in schizophrenia over 50 years. British Medical Journal, 317, 1181–1184.

    Article  Google Scholar 

  • Wessely S. (2001). Randomised controlled trials: The gold standard? In Mace C. Moorey S. & Roberts B. (Eds), Evidence in the balance, 46–60. Hove: Routledge.

    Google Scholar 

  • Wessely S., Bisson J., & Rose S. (2000). A systematic review of brief psychological interventions (‘debriefing’) for the treatment of immediate trauma-related symptoms and the prevention of post-traumatic stress disorder. In Oakley-Browne M. Churchill R. Gill D. Trivedi M. & Wessely S. (Eds), Depression, anxiety and neurosis: Module of the Cochrane database of systematic reviews. Oxford: Update Software.

    Google Scholar 

  • White P. (Ed.) (2005). Biopsychosocial medicine: An integrated approach to understanding illness. Oxford: Oxford University Press.

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Psychiatry, King's College London, De Crespigny Park, London, SE5 8AF, UK

    Simon Wessely

Authors
  1. Simon Wessely
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wessely, S. A Defence of the Randomized Controlled Trial in Mental Health. BioSocieties 2, 115–127 (2007). https://doi.org/10.1017/S1745855207005091

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1017/S1745855207005091

Search

Navigation